ERBB2 and breast cancer: Indeed, a recent study showed a CDK12-dependent transcriptional upregulation of IRS1 and WNT ligands leading to the activation of oncogenic ERBB–PI3K–AKT and WNT signalling pathways in HER2-positive breast cancer (110).